Report from the (TCT) Scientific Symposium, 27 October – 1 November, San Francisco. A new study found that both drug-eluting stents (DES) with biocompatible polymers and DES with… read more.
Report from the Transcatheter Cardiovascular Therapeutics (TCT) Scientific Symposium, 27 October – 1 November, San Francisco. Length of infection increases risk for atherosclerosis. HIV infection, not antiretroviral therapy… read more.
Report from the (TCT) Scientific Symposium, 27 October – 1 November, San Francisco. Clinical trial finds that a strategy of using of a bare metal stent in the… read more.
Report from the (TCT) Scientific Symposium, 27 October – 1 November, San Francisco. A clinical trial shows that rapidly cooling patients who have suffered ST-elevation myocardial infarction (STEMI,… read more.
Report from the Transcatheter Cardiovascular Therapeutics (TCT) Scientific Symposium, 27 October – 1 November, San Francisco. Results of the EUROMAX trial presented at TCT 2013; findings simultaneously published… read more.
by Bruce Sylvester – Cholesterol lowering statin therapy appears to also reduce inflammation associated with gum disease, researchers reported on Oct. 2, 2013 in the Journal of the American… read more.
by Bruce Sylvester – A newly published meta-analysis suggests that influenza vaccination lowers the risk of major adverse cardiovascular events like heart failure or hospitalization for heart attack,… read more.
World Psoriasis Day is 29 October 2013. World Psoriasis Day is held today with the theme “Global access to treatment” to highlight the fact that more than 125… read more.
These activities as good as exercise because they decrease total sedentary time. A spot of DIY or gardening can cut the risk of a heart attack/stroke and prolong… read more.
by Bruce Sylvester – A new meta-analysis of clinical trials evaluating the use of statin medications to prevent heart attacks suggests that the drugs do not threaten short-term… read more.
Statins might help prevent dementia and cataracts, according to two studies.
by Michel Komajda (pictured right) – DPP4 inhibitors are a new class of glucose lowering agents which act on the incretin pathway.
Advertisment
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
